Skeletal and mineral metabolic effects of risedronate in a rat model of high-turnover renal osteodystrophy

[1] Nickolas TL(2006)Relationship between moderate to severe kidney disease and hip fracture in the United States J Am Soc Nephrol 17 3223-3232

[2] McMahon DJ(2007)Renal function and risk of hip and vertebral fractures in older women Arch Intern Med 167 133-139

[3] Shane E(2014)High rates of death and hospitalization follow bone fracture among hemodialysis patients Kidney Int 85 166-173

[4] Ensrud KE(2006)Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO) Kidney Int 69 1945-1953

[5] Lui LY(2004)Mineral metabolism, mortality, and morbidity in maintenance hemodialysis J Am Soc Nephrol 15 2208-2218

[6] Taylor BC(2006)PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis Am J Kidney Dis 47 149-156

[7] Ishani A(2006)Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the dialysis outcomes and practice patterns study Kidney Int 70 1358-1366

[8] Shlipak MG(2015)Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism Kidney Int 87 846-856

[9] Stone KL(2015)Effects of cinacalcet on fracture events in patients receiving hemodialysis: the EVOLVE trial J Am Soc Nephrol 26 1466-1475

[10] Cauley JA(2003)Changes of bone remodeling immediately after parathyroidectomy for secondary hyperparathyroidism Am J Kidney Dis 42 729-738

[1] Nickolas TL(2006)Relationship between moderate to severe kidney disease and hip fracture in the United States J Am Soc Nephrol 17 3223-3232

[2] McMahon DJ(2007)Renal function and risk of hip and vertebral fractures in older women Arch Intern Med 167 133-139

[3] Shane E(2014)High rates of death and hospitalization follow bone fracture among hemodialysis patients Kidney Int 85 166-173

[4] Ensrud KE(2006)Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO) Kidney Int 69 1945-1953

[5] Lui LY(2004)Mineral metabolism, mortality, and morbidity in maintenance hemodialysis J Am Soc Nephrol 15 2208-2218

[6] Taylor BC(2006)PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis Am J Kidney Dis 47 149-156

[7] Ishani A(2006)Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the dialysis outcomes and practice patterns study Kidney Int 70 1358-1366

[8] Shlipak MG(2015)Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism Kidney Int 87 846-856

[9] Stone KL(2015)Effects of cinacalcet on fracture events in patients receiving hemodialysis: the EVOLVE trial J Am Soc Nephrol 26 1466-1475

[10] Cauley JA(2003)Changes of bone remodeling immediately after parathyroidectomy for secondary hyperparathyroidism Am J Kidney Dis 42 729-738